Home / Germany / STADA Arzneimittel Aktiengesellschaft
STADA Arzneimittel Aktiengesellschaft Short position disclosed on March 30, 2015.
Follow
0.54% of the capital sold short
1 disclosing fund
140 disclosures on record
DE0007251803 ISIN code
Evolution of the disclosed total 0% 0.2% 0.4% 0.6%
Oct 2025 Jan 2026 Apr 2026 Jul 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up. The whole history, peaking at 3.92% on March 2, 2016. The shaded band is the year shown above. November 1, 2012 today
Open positions Follow by RSS
Get the moves on STADA Arzneimittel Aktiengesellschaft by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures 140 disclosures on record for this share. Date Fund % of capital End of publication July 24, 2018 Parvus Asset Management Europe Limited 0.00% August 23, 2017 Polygon Global Partners LLP 0.00% August 22, 2017 Polygon Global Partners LLP 0.95% August 21, 2017 Polygon Global Partners LLP 0.82% May 25, 2017 Sand Grove Capital Management LLP 0.23% May 16, 2017 Sand Grove Capital Management LLP 0.00% May 10, 2017 Sand Grove Capital Management LLP 0.47% April 27, 2017 Sand Grove Capital Management LLP 0.33% August 1, 2016 Marshall Wace LLP 0.46% July 29, 2016 Marshall Wace LLP 0.50% July 27, 2016 Marshall Wace LLP 0.49% July 19, 2016 Marshall Wace LLP 0.59% June 29, 2016 Marshall Wace LLP 0.69% June 27, 2016 Marshall Wace LLP 0.77% June 16, 2016 Marshall Wace LLP 0.88% June 15, 2016 Marshall Wace LLP 0.90% June 10, 2016 Marshall Wace LLP 0.82% June 8, 2016 Marshall Wace LLP 0.73% June 6, 2016 Marshall Wace LLP 0.68% June 1, 2016 Marshall Wace LLP 0.70% May 31, 2016 GAM Investment Management (switzerland) AG 0.49% May 30, 2016 GAM Investment Management (switzerland) AG 0.55% May 27, 2016 Marshall Wace LLP 0.69% May 27, 2016 GAM Investment Management (switzerland) AG 0.64% May 26, 2016 Marshall Wace LLP 0.59% May 25, 2016 Marshall Wace LLP 0.60% May 18, 2016 GAM Investment Management (switzerland) AG 0.77% May 17, 2016 Marshall Wace LLP 0.77% May 12, 2016 Marshall Wace LLP 0.89% May 10, 2016 Marshall Wace LLP 0.91% May 9, 2016 Marshall Wace LLP 0.89% May 6, 2016 Marshall Wace LLP 0.90% May 5, 2016 Marshall Wace LLP 0.88% May 4, 2016 Marshall Wace LLP 0.90% May 3, 2016 Marshall Wace LLP 1.12% April 26, 2016 Marshall Wace LLP 1.47% April 19, 2016 Marshall Wace LLP 1.59% April 18, 2016 Parvus Asset Management Europe Limited 0.60% March 18, 2016 Marshall Wace LLP 1.61% March 15, 2016 Marshall Wace LLP 1.59% March 14, 2016 Marshall Wace LLP 1.61% March 10, 2016 Marshall Wace LLP 1.73% March 7, 2016 Marshall Wace LLP 1.96% March 2, 2016 Marshall Wace LLP 2.00% March 1, 2016 Marshall Wace LLP 1.90% February 25, 2016 Marshall Wace LLP 1.80% February 23, 2016 Marshall Wace LLP 1.74% February 16, 2016 Marshall Wace LLP 1.60% February 12, 2016 Marshall Wace LLP 1.51% February 9, 2016 Marshall Wace LLP 1.40%
Download 140 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Page 1 of 3
Other companies sold short in Germany Cite this page The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, STADA Arzneimittel Aktiengesellschaft, source Bundesanzeiger, data as at March 30, 2015, https://www.quivad.com/action/stada-arzneimittel-aktiengesellschaft